Kazu Matsuda

Multi-Indication Radiosensitizing Platform to enhance Radiotherapy & Immunotherapy Effectiveness, Kortuc

United States

Kazu Matsdua is a serial entrepreneur with a successful exit track record. Prior to this, he started off as a biotech investment banker at Mitsubishi and Merril Lynch. He studied Economics at University of Tokyo and earned and MBA at INSEAD (France, Abu Dhabi, Singapore).